Summary
Preliminary results of a cooperative pilot study on the effect of fibroblast interferon in 10 patients with NHL of low-grade malignancy are presented. In eight patients lymphoma progression forced a discontinuation of therapy. At the end of interferon treatment one patient with CBCC showed a stable disease, one patient with CBCC a minor partial remission.
Similar content being viewed by others
Literatur
Interferon nomenclature (1980) Nature 286: 110
Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M (1971) Report of the committee on Hodgkin's disease staging classification. Cancer Res 31: 1860
Gérard-Marchant R, Hamlin J, Lennert K, Rilke F, Stansfeld AD, van Unnik JAM (1974) Classification of Non-Hodgkin-Lymphomas. Lancet II: 406
Gutterman JU, Blumenschein GR, Alexanian R, Yap HY, Buzdar AU, Cabanillas F, Hortobagyi GN, Hersh EM, Rasmussens SL, Harmon M, Kramer M, Pestka S (1980) Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma. Ann Intern Med 93: 399
Merigan TC, Sikora K, Breeden JH, Levy R, Rosenberg SA (1978) Preliminary observations on the effect of human leukocyte interferon in Non-Hodgkin's lymphoma. N Engl J Med 299: 1449
Misset JL, Goutner A, Mathé G (1980) Clinical and immunological experience in B-cell malignancies. 6th Ann Meeting, Europ Soc Med Oncology, Nice Dec 6–8. Cancer Immunol Immunother [Suppl] 5: 35
Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS (1975) Clinical staging of chronic lymphocytic leukemia. Blood 46: 219
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fink, U., Siegert, W., Huhn, D. et al. Fibroblasten-Interferon-Therapie (Hu IFN-β) bei Non-Hodgkin-Lymphomen (NHL) mit niedrigem Malignitätsgrad: Vorläufige Ergebnisse. Blut 44, 121–124 (1982). https://doi.org/10.1007/BF00320101
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00320101